Barclays’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-17,361
Closed -$216K 4301
2016
Q4
$216K Buy
17,361
+5,120
+42% +$63.7K ﹤0.01% 2264
2016
Q3
$167K Buy
12,241
+6,436
+111% +$87.8K ﹤0.01% 2220
2016
Q2
$43K Sell
5,805
-19,617
-77% -$145K ﹤0.01% 2623
2016
Q1
$153K Sell
25,422
-218,333
-90% -$1.31M ﹤0.01% 2173
2015
Q4
$1.46M Buy
243,755
+183,523
+305% +$1.1M ﹤0.01% 1191
2015
Q3
$301K Buy
60,232
+49,699
+472% +$248K ﹤0.01% 1952
2015
Q2
$84K Sell
10,533
-23,254
-69% -$185K ﹤0.01% 2429
2015
Q1
$270K Sell
33,787
-96,776
-74% -$773K ﹤0.01% 2161
2014
Q4
$783K Buy
130,563
+46,261
+55% +$277K ﹤0.01% 1754
2014
Q3
$422K Sell
84,302
-3,038
-3% -$15.2K ﹤0.01% 2017
2014
Q2
$525K Sell
87,340
-37,610
-30% -$226K ﹤0.01% 1985
2014
Q1
$999K Sell
124,950
-1,801,931
-94% -$14.4M ﹤0.01% 1666
2013
Q4
$11.6M Buy
1,926,881
+1,727,814
+868% +$10.4M 0.01% 654
2013
Q3
$3.58M Buy
199,067
+106,152
+114% +$1.91M ﹤0.01% 1016
2013
Q2
$1.63M Buy
+92,915
New +$1.63M ﹤0.01% 1429